Allovir Inc
For the period ended Dec 31, 2024. Filed Mar 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 7, 2025
KLRS$2.30-5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| (in thousands, except share and per share amounts) | 2024 | 2023 |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $118,289 | $90,121 |
| Short-term investments | — | 93,822 |
| Interest receivable | — | 206 |
| Prepaid expenses and other current assets | 257 | 3,486 |
| Total current assets | 118,546 | 187,635 |
| Restricted cash | — | 852 |
| Other assets | — | 122 |
| Operating lease right-of-use assets | — | 2,187 |
| Total assets | $118,546 | $190,796 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $247 | $6,761 |
| Accrued expenses | 4,992 | 10,086 |
| Operating lease liability, current | — | 10,781 |
| Amount due to related party | — | 739 |
| Total current liabilities | 5,239 | 28,367 |
| Operating lease liability, long-term | — | 16,648 |
| Total liabilities | $5,239 | 45,015 |
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value: 10,000,000 shares authorized at December 31, 2024 and December 31, 2023, respectively; 0 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively | — | — |
| Common stock, $0.0001 par value: 300,000,000 and 150,000,000 shares authorized at December 31, 2024 and December 31, 2023, respectively; 5,040,640 and 4,963,197 shares issued at December 31, 2024 and December 31, 2023, respectively; and 5,040,640 and 4,962,997 shares outstanding at December 31, 2024 and December 31, 2023, respectively | — | — |
| Additional paid-in capital | 828,404 | 802,036 |
| Accumulated other comprehensive loss | (135) | (62) |
| Accumulated deficit | (714,962) | (656,193) |
| Total stockholders’ equity | 113,307 | 145,781 |
| Total liabilities and stockholders’ equity | $118,546 | $190,796 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.